earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to evaluate the effect of early rehabilitation treatment by electroencephalographic neurofeedback on upper limb motor function after stroke. Researchers will compare : Interventional group: electroencephalographic neurofeedback + traditional reference rehabilitation programme Control group: SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Unilateral ischaemic or haemorrhagic stroke

• Adult (18-80 years), both sexes

• Stroke \< 3 weeks

• Upper limb deficit defined by Shoulder Abduction Finger Extension score \<5 on day 3 of stroke; i.e., patients predicted to have incomplete recovery

• No participation-limiting comprehension problems

• With or without homonymous lateral hemianopia; with or without visuospatial hemineglect

• Free, informed and written consent signed by the patient or a member of the patient's family (in the case of a patient who is able to understand the information and give consent but has motor difficulties resulting in an invalid signature).

• Affiliated to french social security

Locations
Other Locations
France
Rennes Chu
RECRUITING
Rennes
Contact Information
Primary
LOÏC JACOB
loic.jacob@chu-rennes.fr
0299282555
Time Frame
Start Date: 2024-02-20
Estimated Completion Date: 2026-01-20
Participants
Target number of participants: 40
Treatments
Experimental: Interventional group
electroencephalographic neurofeedback + traditional reference rehabilitation programme
Sham_comparator: Control group
SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme
Related Therapeutic Areas
Sponsors
Leads: Rennes University Hospital
Collaborators: Fondation de l'Avenir

This content was sourced from clinicaltrials.gov